Novanta Inc. (NOVT)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 591 | 707 | 861 | 882 | 949 | 981 | 1,030 | 1,133 |
| Operating profit | $m | 117 | 107 | ||||||
| Net profit | $m | 45 | 50 | 74 | 73 | 64 | 54 | 62 | 136 |
| EPS reported | $ | 1.47 | 1.56 | ||||||
| Operating cashflow per share | $ | 1.75 | 3.26 | ||||||
| Capex per share | $ | 0.43 | 0.48 | ||||||
| FCF per share | $ | 1.32 | 2.79 | ||||||
| Free cash flow | $m | 48 | 114 | ||||||
| Net debt | $m | -80 | -479 | ||||||
| Book value equity | $m | 1,314 | 1,616 | ||||||
| Book value per share | $ | 35.81 | 39.27 | ||||||
| Number of shares | m | 36.7 | 41.16 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 80.95 | 92.26 | ||||||
| P/B LTM | x | 3.31 | 2.69 | ||||||
| P/S LTM | x | 4.44 | 4.23 | ||||||
| P/FCF LTM | x | 89.90 | 38.10 | ||||||
| EV/EBITDA LTM | x | 28.19 | 30.91 | ||||||
| EV/Sales LTM | x | 4.40 | 5.34 | ||||||
| Earnings Yield LTM | % | +1.24% | +1.08% | ||||||
| FCF Yield | % | +1.11% | +2.62% | ||||||
| Quality | |||||||||
| ROE | % | +4.10% | +4.90% | ||||||
| ROIC | % | +5.49% | +4.28% | ||||||
| Operating margin | % | +11.90% | +10.43% | ||||||
| Gross margin | % | +41.59% | +42.52% | ||||||
| FCF/Sales | % | +4.94% | +11.10% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -16.95% | -11.86% | ||||||
| Sales Growth YoY | % | +3.30% | +8.48% | ||||||
| Net Income Growth YoY | % | -16.01% | -3.62% | ||||||
| FCF Growth | % | -65.74% | -19.15% | ||||||
| Operating Profit Growth | % | +5.50% | -2.86% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.14 | 0.40 | ||||||
| Net Debt/EBITDA | x | -0.26 | -3.12 | ||||||
| EBIT/Net interest | x | 5.43 | 8.29 | ||||||
| Net debt/market cap | % | +6.90% | +3.87% | ||||||
| Net debt/Equity | x | -0.06 | -0.30 | ||||||
| Gross debt/equity | x | 0.26 | 0.17 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free